TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Tarpoon Bioscience AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
76
|
123
|
135 |
| Financial expenses |
0
|
0
|
13 |
| Earnings before taxes |
46
|
23
|
15 |
| EBITDA |
44
|
21
|
28 |
| Total assets |
297
|
283
|
291 |
| Current assets |
101
|
87
|
90 |
| Current liabilities |
9
|
21
|
19 |
| Equity capital |
274
|
249
|
257 |
| - share capital |
9
|
9
|
10 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
92.3%
|
88.0%
|
88.3% |
| Turnover per employee |
76
|
123
|
135 |
| Profit as a percentage of turnover |
60.5%
|
18.7%
|
11.1% |
| Return on assets (ROA) |
15.5%
|
8.1%
|
9.6% |
| Current ratio |
1122.2%
|
414.3%
|
473.7% |
| Return on equity (ROE) |
16.8%
|
9.2%
|
5.8% |
| Change turnover |
-48
|
-1
|
3 |
| Change turnover % |
-39%
|
-1%
|
2% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.